Limiting the role of antibiotics in children with adenotosilitis

Background In the past, group A beta-haemolytic streptococcus infection consequences were the main goal of empirical antibiotic therapy of sore throat. Antimicrobial stewardship is crucial due to the threats posed by multi-resistant pathogens. The aim of this study : was to investigate the possibility of limiting the role of antibiotic in children with adenotosilitis  Methods: This hospital-based, randomised, prospective research involved 120 child who visited OPD of both Pediatrics and Otorhinolaryngology departments,  pesented with adenotonsillitis  were enrolled . All cases met the eligibility requirements were randomly assigned to two groups: 60 cases in Group A got systemic antibiotics. Group B 60 cases received symptomatic treatment with  immune modulator, vit D 2000-5000 IU orally once daily. The cases were selected through 2 months from February 2022 to April 2022. Age :2 years  to 9  years. In  younger children less than 3 years, dysphagia was expressed by the mothers as difficult swallowing and crying  during feeding with drolling of saliva. Results: Regarding baseline symptoms and indicators and after three days, there was no discernible difference between groups A and B. However, after six days of therapy, group B considerably outperformed group A in terms of absent sore throat, dysphagia, and tonsillar hypertrophy.&nbsp